Drug Database
Back to search

Poland· PL-100522961

Belosalic

A betamethasone product containing betamethasonum + acidum salicylicum, registered in Poland by Medezin Sp. z o.o.. The same ATC class is registered in 11 of our 19 countries.

ATC D07XC01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedBelosalicATCD07XC01REGISTER NO.PL-100522961PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about betamethasonum + acidum salicylicumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Betamethasone is registered in 11 of 19 countries.

Countries holding a registration under ATC D07XC01 (betamethasone), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search betamethasone products by name

Betamethasone · ATC D07XC01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Betamethasonum + Acidum salicylicum
Manufacturer
Medezin Sp. z o.o.
Country
Poland (PL)
ATC code
D07XC01
ATC class
Betamethasone
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991582883

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

55 interactions on record for betamethasone.

Graded by severity as the source publishes them — 55 minor. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check betamethasone against other medicinesHow interaction checks work

Betamethasone · interactions on record

55 records

  • 55 minor

Most severe, free to view

    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same medicine, other countries

    Betamethasone in 13 other countries

    What each register calls a product with the same active substance — salts and hydrates count as the same.

    All betamethasone products

    Authorised across Europe · EMA

    The same active substance is authorised in 24 EEA countries. Names it is sold under:

    • Austria · Betamethason/Salicylsäure Dermapharm, Diprosalic
    • Belgium · Diprosalic
    • Bulgaria · Бетадерм А, Дипросалик
    • Czechia · Belosalic, Diprosalic
    • Germany · Betadermic, Betasacyl
    • Denmark · Betamethason/Salicylsyre Orifarm, Diprosalic
    • Estonia · Diprosalic
    • Spain · Diprosalic, Syracerin
    • Finland · Diprosalic
    • France · Diprosalic
    • United Kingdom (Northern Ireland) · Betamethasone + Salicylic Acid Penlan Pharmaceuticals, Betamethasone/Salicylic Acid Penlan Pharmaceuticals
    • Croatia · Belosalic, Soderm Plus
    • Hungary · Diprosalic
    • Ireland · Diprosalic
    • Iceland · Diprosalic
    • Italy · Belasic, Diprosalic
    • Luxembourg · Diprosalic
    • Netherlands · Diprosalic
    • Norway · Diprosalic
    • Portugal · Diprosalic, Psodermil
    • Romania · Diprosalic, Sal-Ekarzin
    • Sweden · Betametason/Salicylsyra Orifarm, Diprosalic
    • Slovenia · Belosalic, Diprosalic
    • Slovakia · Belosalic

    Source: European Medicines Agency, Article 57 product data.

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/ed346a05-97f3-41bf-93e2-50c032de774c
GET /v1/drugs/ed346a05-97f3-41bf-93e2-50c032de774c?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "form": "Roztwór na skórę",
  "source": "urpl",
  "strength": "(0,5 mg + 20 mg)/g",
  "packaging": "05909991582883 ¦ Rp ¦ 163354\n1 butelka 50 ml",
  "substance": "Betamethasonum 0.5 mg/g + Acidum salicylicum 20 mg/g",
  "common_name": "Betamethasonum + Acidum salicylicum",
  "pl_product_id": "100522961",
  "pozwolenie_nr": "269/25",
  "auth_procedure": "IR",
  "authorisation_validity": "2030-08-20"
}
    API referenceMCP serverPlans

    See everything about betamethasone.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console